Douglas A. Mata

7.9k total citations · 3 hit papers
97 papers, 5.0k citations indexed

About

Douglas A. Mata is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Douglas A. Mata has authored 97 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Douglas A. Mata's work include Cancer Genomics and Diagnostics (22 papers), Healthcare professionals’ stress and burnout (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Douglas A. Mata is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Healthcare professionals’ stress and burnout (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Douglas A. Mata collaborates with scholars based in United States, Italy and United Kingdom. Douglas A. Mata's co-authors include Srijan Sen, Constance Guille, Marco A. Ramos, Lisa S. Rotenstein, Matthew Torre, Michael J. Peluso, Jacob Segal, Rachael Rosales, Rida Khan and Emanuele Di Angelantonio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Douglas A. Mata

86 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students

2016 1.6k citations Srijan Sen, Douglas A. Mata et al. profile →
Prevalence of Burnout Among Physicians

2018 1.2k citations Srijan Sen, Douglas A. Mata et al. profile →
Prevalence of Depression and Depressive Symptoms Among Resident Physicians

2015 842 citations Douglas A. Mata, Srijan Sen et al. profile →

Peers

Countries citing papers authored by Douglas A. Mata

Since Specialization

Citations

This map shows the geographic impact of Douglas A. Mata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Mata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Mata more than expected).

Fields of papers citing papers by Douglas A. Mata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Mata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Mata. The network helps show where Douglas A. Mata may publish in the future.

Co-authorship network of co-authors of Douglas A. Mata

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Mata. A scholar is included among the top collaborators of Douglas A. Mata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Mata. Douglas A. Mata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	49 Expanding the Clinicopathologic Spectrum of Sarcomas with EWSR1::SSX Fusions 2025 ·Laboratory Investigation ·John Gross, David Suster, Douglas A. Mata, Markku Miettinen, Gregory W. Charville	1
2	Expanding the Clinicopathologic Spectrum of EWSR1::SSX-Rearranged Sarcomas: Series of 11 Cases Including Osteosarcomas and a Novel EWSR1::SSX4 Fusion 2025 ·Modern Pathology ·John Gross, David Suster, Ying Zou, Douglas A. Mata, Fernanda Amary, (unknown), Adrienne M. Flanagan, (unknown), (unknown), Fei Dong, Suk Wai Lam, Judith V.M.G. Bovée, (unknown), Daniel Pissaloux, Éric Pasmant, Fréderique Larousserie, Markku Miettinen, Meera Hameed, Gregory W. Charville	0
3	Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results 2024 ·Histopathology ·Douglas A. Mata, Jessica Lee, Vignesh Shanmugam, (unknown), Alexa B. Schrock, Erik A. Williams, Lauren L. Ritterhouse, Richard A. Hickman, Tyler Janovitz, Nimesh R. Patel, Benjamin Kroger, Jeffrey S. Ross, Kamran Mirza, Geoffrey R. Oxnard, Jo‐Anne Vergilio, Julia A. Elvin, Jamal Benhamida, Brennan Decker, Mina L. Xu	5
4	Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma 2024 ·The American Journal of Surgical Pathology ·Erik A. Williams, (unknown), Fardous F. El‐Senduny, (unknown), Douglas A. Mata, Matthew Hiemenz, Sarah Hughes, (unknown), (unknown), (unknown), (unknown), (unknown), Clara Milikowski, Kevin Jon Williams, Jeffrey S. Ross, Razelle Kurzrock, Elizabeth A. Montgomery, David B. Lombard, Surinder Kumar	3
5	Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis? 2023 ·Modern Pathology ·Jaylou M. Velez Torres, Douglas A. Mata, (unknown), (unknown), Jeffrey M. Cloutier, Darcy A. Kerr, Elizabeth A. Montgomery, Andrew E. Rosenberg	5
6	Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation 2023 ·Journal of Thoracic Oncology ·Soo‐Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, Jason C. Chang, (unknown), Douglas A. Mata, Liliana Villafania, Khédoudja Nafa, Jaclyn F. Hechtman, Ryma Benayed, Ahmet Zehir, Jamal Benhamida, Maria E. Arcila, Diana Mandelker, Charles M. Rudin, Paul K. Paik, Alexander Drilon, Adam J. Schoenfeld, Marc Ladanyi	14
7	Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma 2022 ·Modern Pathology ·(unknown), Tyler Janovitz, (unknown), Douglas A. Mata, Meagan Montesion, Jessica Lee, Russell W. Madison, Alexa B. Schrock, Hanna Tukachinsky, Justin Allen, Rachel Erlich, Matthew Hiemenz, Richard S.P. Huang, Julia A. Elvin, Jo‐Anne Vergilio, Douglas I. Lin, Jeffrey S. Ross, Geoffrey R. Oxnard, Brennan Decker	2
8	DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival 2022 ·Acta Neuropathologica ·Zhichao Wu, Osório Lopes Abath Neto, Tejus Bale, Jamal Benhamida, Douglas A. Mata, Rust Turakulov, Zied Abdullaev, Daniel F. Marker, (unknown), Hye‐Jung Chung, Caterina Giannini, Martha Quezado, Drew Pratt, Kenneth Aldape	15
9	Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression 2021 ·Journal for ImmunoTherapy of Cancer ·Richard S.P. Huang, Brennan Decker, Karthikeyan Murugesan, Matthew Hiemenz, Douglas A. Mata, Gerald Li, James Creeden, Shakti Ramkissoon, Jeffrey S. Ross	8
10	Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression 2021 ·Journal for ImmunoTherapy of Cancer ·Richard S.P. Huang, Karthikeyan Murugesan, Meagan Montesion, Dean C. Pavlick, Douglas A. Mata, Matthew Hiemenz, Brennan Decker, Garrett M. Frampton, Lee A. Albacker, Jeffrey S. Ross	16
11	Significance of Paneth cell–like differentiation in prostatic adenocarcinoma: a retrospective cohort study of 80 cases 2020 ·Human Pathology ·Daniela C. Salles, Douglas A. Mata, Jonathan I. Epstein	5
12	A Performance Comparison of Commonly Used Assays to Detect RET Fusions 2020 ·Clinical Cancer Research ·Soo‐Ryum Yang, Umut Aypar, Ezra Y. Rosen, Douglas A. Mata, Ryma Benayed, Kerry Mullaney, Gowtham Jayakumaran, Yanming Zhang, Denise Frosina, Alexander Drilon, Marc Ladanyi, Achim A. Jungbluth, Natasha Rekhtman, Jaclyn F. Hechtman	50
13	Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate 2020 ·JTO Clinical and Research Reports ·Maria E. Arcila, Soo‐Ryum Yang, (unknown), Douglas A. Mata, Paulo Salazar, (unknown), (unknown), Ryma Benayed, Ahmet Zehir, Darren J. Buonocore, Natasha Rekhtman, Oscar Lin, Marc Ladanyi, Khédoudja Nafa	30
14	Racial and Ethnic Diversity and Depression in Residency Programs: a Prospective Cohort Study 2019 ·Journal of General Internal Medicine ·Jad A. Elharake, Elena Frank, David A. Kalmbach, Douglas A. Mata, Srijan Sen	11
15	Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology 2017 ·npj Precision Oncology ·Shuji Ogino, Iny Jhun, Douglas A. Mata, T. Rinda Soong, Tsuyoshi Hamada, Li Liu, Reiko Nishihara, Marios Giannakis, Yin Cao, JoAnn E. Manson, Jonathan A. Nowak, Andrew T. Chan	9
16	A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols 2017 ·Journal of Assisted Reproduction and Genetics ·(unknown), Douglas A. Mata, (unknown), Hakan Çakmak, Marcelle I. Cedars, Mitchell P. Rosen	8
17	Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study 2016 ·Bladder Cancer ·(unknown), Douglas A. Mata, Oleksandr N. Kryvenko, Anup Shah, Iny Jhun, Seth P. Lerner	12
18	Neuropathology: bridging psychiatry and neurology in medical education 2016 ·The Lancet Psychiatry ·Paras S. Minhas, YunXiang Chu, Douglas A. Mata	1
19	Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive azoospermia: a systematic review and meta-analysis 2015 ·Fertility and Sterility ·Aaron Bernie, Douglas A. Mata, Ranjith Ramasamy, Peter N. Schlegel	187
20	A 25-Year-Old Man with Exudative Retinal Detachments and Infiltrates without Hematological or Neurological Findings Found to Have Relapsed Precursor T-Cell Acute Lymphoblastic Leukemia 2015 ·Case Reports in Ophthalmology ·(unknown), (unknown), (unknown), Chanping Liang, Douglas A. Mata	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact